BionIT Labs
PrivateLast Round
Series A
Jul 3, 2024
Est. Valuation
$1.97M
Total Funding Raised
$10.59M
Company Overview
BionIT Labs operates in Healthcare & Life Sciences and is based in Soleto. Its latest recorded funding round was a Series A round in July 2024.
BionIT Labs is a medical technology company that develops Adam's Hand, a fully-adaptive bionic hand prosthesis designed to improve the quality of life for people with upper-limb differences.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BionIT Labs Comparables
Compare BionIT Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Esper Bionics | 94% | |
| Aether Biomedical | 87% | |
| COVVI | 87% |
For institutional investors. Book with your work email.
BionIT Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 3, 2024 | ||||
| Seed | Nov 22, 2021 | ||||
| VC Round | Dec 1, 2020 | ||||
| Crowdfunding | Sep 18, 2019 | ||||
| Grant | Aug 23, 2019 | ||||
Accelerator | Mar 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BionIT Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDP Venture Capital SGR | Series A, VC Round, Seed |
| SEFEA Impact | Series A |
| G-Factor | Accelerator |
| SIMEST | Series A |
| ENEA-Tech and Biomedical Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Demonstrated AI bionic prosthetic hand at CES 2026.
- Sep 26, 2025
Closed Canadian and Americas offices on September 26, 2025.
For institutional investors. Book with your work email.
BionIT Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BionIT Labs's valuation, stock price, and market status.
Is BionIT Labs a public or private company?
BionIT Labs is a private company.
What is the current stock price of BionIT Labs?
BionIT Labs is a private company, so its shares have no public market price. Caplight tracks BionIT Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BionIT Labs worth (valuation)?
BionIT Labs's valuation is estimated at $2.0M based on funding round data.
Can I buy BionIT Labs stock?
BionIT Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BionIT Labs's last funding round?
BionIT Labs's most recent funding round was Series A on July 3, 2024.
Who are the main investors in BionIT Labs?
Key investors in BionIT Labs include CDP Venture Capital SGR, G-Factor.
Will BionIT Labs IPO soon?
No public IPO plans have been announced for BionIT Labs.
How can I track BionIT Labs secondary market activity?
Caplight tracks bids, offers, and trades in BionIT Labs's shares on secondary markets.